References
- MacKinlay S M., Jefferys M. The menopausal syndrome. Br J Prev Soc Med 1974; 28: 108–15
- Ginsburg J, Swinhoe J, O'Reilly B. Cardiovascular responses during the menopausal hot flush. Br J Obstet Gynaecol 1981; 88: 925–30
- Lightman S L., Jacobs H S., Maguire A K. Down-regulation of gonadotropin secretion in postmenopausal women by a superactive LHRH analogue: Lack of effect on menopausal flushing. Br J Obstet Gynaecol 1982; 89: 977–80
- Duncan S LB. Menopausal flushing: where now?. Br J Obstet Gynaecol 1982; 89: 975–6
- Lightman S L., Jacobs H S., Maguire A K., McGarrick G, Jeffcoate S L. Climacteric flushing: clinical and endocrine response to infusion of naloxone. Br J Obstet Gynaecol 1981; 88: 919–24
- Eaton A C., McGuire N. Cyproterone acetate in treatment of post-orchidectomy hot flushes. Lancet 1983; ii: 1336–7
- Clayden J R., Bell J W., Pollard P. Menopausal flushing: Double-blind trial of a non-hormonal medication. Br Med J 1974; i: 409–12
- Townsend P T., Whitehead M I., McQueen J, Minardi J, Campbell S. Double-blind studies on the effects of natural estrogens on postmenopausal women: A follow-up report. The Menopause and Postmenopause, N Pasetto, R Paoletti, J L. Ambrus. MTP Press, Lancaster 1980; 75–84
- Ottosson U B. Oral progesterone and estrogen/progestogen therapy. Effects of natural and synthetic hormones on subfractions of HDL cholesterol and liver proteins. Acta Obstet Gynecol Scand (Suppl) 1984; 127: 5–37
- Lyrenas S, Carlstrom K, Backstrom T, von Schoultz B. A comparison of serum oestrogen levels after percutaneous and oral administration of estradiol-17β. Br J Obstet Gynaecol 1981; 88: 181–7
- Helgason S, Damber M G., von Schoultz B, Stigbrand T. Estrogenic potency or oral replacement therapy estimated by the induction of pregnancy zone protein. Acta Obstet Gynecol Scand 1981; 60: 75–9
- Helgason S. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Acta Obstet Gynecol Scand (Suppl) 1982; 107
- Elkik F, Gompel A, Mercier-Bodard C, Kuttenn F, Guyenne P N., Corvol P, Mauvais-Jarvis P. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. Am J Obstet Gynecol 1982; 143: 888–92
- Fåhraeus L, Wallentin L. High density lipoprotein sub-fractions during oral and cutaneous administration of 17β-estradiol to menopausal women. J Clin Endocrinol Metab 1983; 56: 797–801
- Judd H L., Cleary R E., Creasman W T., Figge D C., Kase N, Rosenwaks Z, Tagatz G E. Estrogen replacement therapy. Obstet Gynecol 1981; 58: 267–75
- Hammond C B., Maxson W S. Current status of estrogen therapy for the menopause. Fertil Steril 1982; 37: 5–25